Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients

BMC Nephrology

Volumn 11, Issue 1, 2010, Pages

  Coen, Giorgio ^a   Pierantozzi, Andrea ^a   Spizzichino, Daniele ^a   Sardella, Daniela ^a   Mantella, Daniela ^b   Manni, Micaela ^c   Pellegrino, Luigi ^d   Romagnoli, Andrea ^d   Pacifici, Roberta ^e   Zuccaro, Piergiorgio ^e   Digiulio, Salvatore ^b  

^a Piazza San Bartolomeo All'Isola 21   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CALCIUM; FETUIN A; LEPTIN; ALPHA2HS GLYCOPROTEIN; BIOLOGICAL MARKER; CALCIFEDIOL; PLASMA PROTEIN;

ADULT; ARTERY CALCIFICATION; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CLINICAL EVALUATION; COMPARATIVE STUDY; CORONARY ARTERY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; AGED; BLOOD; CALCINOSIS; CHRONIC KIDNEY FAILURE; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; FOLLOW UP; HOSPITALIZATION; ITALY; MIDDLE AGED; RADIOGRAPHY; RENAL REPLACEMENT THERAPY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STATISTICS; SURVIVAL;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; C-REACTIVE PROTEIN; CALCIFEDIOL; CALCINOSIS; COMORBIDITY; CORONARY DISEASE; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; ROME; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 77954598440     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-11-10     Document Type: Article

References (33)

1. Coronary artery calcification in patients with CRF not undergoing dialysis. D Russo G Palmiero AP De Blasio MM Balletta VE Andreucci, Am J Kidney Dis 2004 44 1024 1030 10.1053/j.ajkd.2004.07.022 15558523
2. Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study. H Kramer R Toto R Peshock R Cooper R Victor, J Am Soc Nephrol 2005 16 507 513 10.1681/ASN.2004070610 15601745 (Pubitemid 41725148)
3. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. WG Goodman J Goldin BD Kuizon C Yoon B Gales D Sider Y Wang J Chung A Emerick L Greaser RM Elashoff IB Salusky, N Eng J Med 2000 342 1478 1483 10.1056/NEJM200005183422003 (Pubitemid 30318271)
4. Clinical epidemiology of cardiovascular disease in chronic renal disease. RN Foley PS Parfrey MJ Sarnak, Am J Kidney Dis 1998 32 Suppl 3 112 119 10.1053/ajkd.1998.v32.pm9820470 9820470
5. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. J Blacher AP Guerin B Pannier SJ Marchais GM London, Hypertension 2001 38 938 942 10.1161/hy1001.096358 11641313
6. Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. GM London, J Am Soc Nephrol 2003 14 305 S309 10.1097/01.ASN.0000081664.65772.EB 12939386
7. Coronary calcification in hemodialysis patients: the contribution of traditional and uremia related risk factors. DV Barreto FC Barreto AB Carvalho L Cuppari M Cendoroglio SA Draibe RM Moyses V Jorgetti A Blair R Guiberteau ME Fernandes Canziani, Kidney Int 2005 67 1576 1582 10.1111/j.1523-1755.2005.00239. x 15780114
8. Cardiac calcifications: fetuin-A and other risk factors in hemodialysis patients. G Coen M Manni A Agnoli A Balducci M Dessi S De Angelis L Jankovic D Mantella M Morosetti A Naticchia I Nofroni A Romagnoli MT Gallucci M Tomassini G Simonetti G Splendiani, ASAIO J 2006 50 150 156 10.1097/01.mat.0000202606. 44826.6b (Pubitemid 44309497)
9. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. A Krasniak M Drozdz M Pasowicz G Chmiel M Michalek D Szumilak P Podolec P Klimeczek M Konieczynska E Wicher-Muniak W Tracz TN Khoa JC Souberbielle TB Drueke W Sulowicz, Nephrol Dial Transplant 2007 22 515 521 10.1093/ndt/gfl564 17050638
10. Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort. U Baber JA de Lemos A Khera DK McGuire T Omland RD Toto SS Hedayati, Kidney Int 2008 73 615 621 10.1038/sj.ki.5002716 18075501
11. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. M Ketteler P Bongartz R Westenfeld JE Wildberger AH Mahnken R Böhm T Metger C Wanner W Jahnen-Dechent J Floege, Lancet 2003 361 827 833 10.1016/S0140- 6736(03)12710-9 12642050
12. Role of calcification inhibitors, in the pathogenesis of vascular calcification in chronic kidney disease (CKD). SM Moe M Reslerova M Ketteler K O'Neill D Duan J Koczman R Westenfeld W Jahnen-Dechent NX Chen, Kidney Int 2005 67 2295 2304 10.1111/j.1523-1755.2005.00333.x 15882271
13. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients? G Coen M Manni D Mantella A Pierantozzi A Balducci S Cond S DiGiulio L Yancovic B Lippi S Manca M Morosetti L Pellegrino G Simonetti MT Gallucci G Splendiani, Nephrol Dial Transplant 2007 22 3262 3267 10.1093/ndt/gfm370 17597083
14. Association of elevated serum PO4, Ca × PO4 product and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. SK Ganesh AG Stack NW Levin T Hulbert-Shearon FK Port, J Am Soc Nephrol 2001 12 2131 2138 11562412
15. Calcium, phosphorus, parathyoid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1,3, qnd 4 study. Y Slinin RN Foley AJ Collins, J Am Soc Nephrol 2005 16 1788 1793 10.1681/ASN.2004040275 15814832
16. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. A Covic P Kothawala M Bernal S Robbins A Chalian D Goldsmith, Nephrol Dial Transplant 2009 24 1506 1523 10.1093/ndt/gfn613 19001560
17. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. J Braun M Oldendorf W Moshage R Heidler E Zeitler FC Luft, Am J Kidney Dis 1996 27 394 401 10.1016/S0272- 6386(96)90363-7 8604709
18. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. GM Chertow SK Burke P Raggi for the Treat to Goal Working Group, Int Kidney 2002 62 245 252 10.1046/j.1523-1755.2002.00434.x (Pubitemid 34754068)
19. Natural history of vascular calcification in dialysis and transplant patients. SM Moe KD O'Neill M Resterova N Fineberg S Persohn CA Meyer, Nephrol Dial Transplant 2004 19 2387 2393 10.1093/ndt/gfh303 15252163
20. How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis? A Bellasi L Kooienga GA Block E Veledar DM Spiegel P Raggi, J Nephrol 2009 22 255 262 19384844
21. Detection of coronary calcinosis with multislice spiral computerized tomography: an alternative to electron beam tomography. A Knez A Becker C Becker A Leber P Boekstegers M Reiser G Steinbeck, Z Kardiol 2002 91 642 649 10.1007/s00392-002-0838-7 12426828
22. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. DS Keith GA Nichols CM Gullion JB Brown DH Smith, Arch Intern Med 2004 164 659 663 10.1001/archinte. 164.6.659 15037495
23. Accelerated atherosclerosis in prolonged maintenance hemodialysis. A Lindner B Charra DJ Sherrard BH Scribner, N Eng J Med 1974 290 697 701
24. Association of serum phosphorus and calcium × phosphate product with mortality in chronic hemodialysis patients: a national study. GA Block TE Hulbert-Shearon NW Levin FK Port, Am J Kidney Dis 1998 31 607 617 10.1053/ajkd.1998.v31.pm9531176 9531176
25. The emerging role of phosphate in vascular calcification. CM Giachelli, Kidney Int 2009 75 890 897 10.1038/ki.2008.644 19145240
26. Slowing the Progression of Vascular Calcification in Hemodialysis. GM Chertow, J Am Soc Nephrol 2003 14 310 S314 10.1097/01.ASN.0000081666.10967.05 12939387
27. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. GA Block DM Spiegel J Ehrlich R Mehta J Lindbergh A Dreisbach P Raggi, Kidney Int 2005 68 1815 1824 10.1111/j.1523-1755.2005. 00600.x 16164659
28. An association between coronary artery calcification score, lipid profile, and selected markers of chronic lnflammation in ESRD patients treated with peritoneal dialysis. T Stompor M Pasowicz W Sulowicz A Dembinska-Kiec K Janda K Wájcik W Tracz A Zdzienicka P Klimczek E Janusz-Grzybowska, Am J Kidney Dis 2003 41 203 211 10.1053/ajkd.2003.50005 12500238
29. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. G Jean E Bresson JC Terrat T t Vanel JM Hurot C Lorriaux B Mayor C Chazot, Nephrol Dial Transplant 2009 24 948 955 10.1093/ndt/gfn571 18852190
30. Arterial calcifications and bone histomorphometry in end-stage renal disease. GM London C Marty SJ Marchais AP Guerin F Metivier MC DeVernejoul, J Am Soc Nephrol 2004 15 1943 1951 10.1097/01.ASN.0000129337.50739.48 15213285
31. Vascular calcifications: contribution of parathyroid hormone in renal failure. KR Neves FG Graciolli LM Dos Reis RG Graciolli CL Neves AO Parathy MR Custodio V Jorgetti RMA Moyses, Kidney Int 2007 71 1262 1270 10.1038/sj.ki.5002241 17410101
32. The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. C Tomiyama A Higa MA Dalboni M Cendoroglio SA Draibe L Cuppari AB Carvalho EM Neto ME Canziani, Nephrol Dial Transplant 2006 21 2464 2471 10.1093/ndt/gfl291 16735378
33. Artery calcifications in uremic rats is increased by a low protein diet and prevented by treatment with Ibandronate. PA Price AM Roublick MK Williamson, Kidney Int 2006 70 1577 1583 10.1038/sj.ki.5001841 16955099